tamoxifen and glp-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways GLP-1s for Patients With Breast

Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey

Some patients, especially those that have struggled longterm with weight issues, will go on a low maintenance dose instead of just abruptly stopping medication

GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension Georgios S

Current utilization patterns of glucagon-like peptide-1 receptor agonists: report [Internet]

Merck did not blindly follow the trend in treating type 2 diabetes and obesity but instead focused on conquering non-alcoholic fatty liver disease

PDF PDF PDF PDF PDF PDF Type 1 Diabetes: Caring for someone with type 1 diabetes Fact sheet for someone caring for a child with type 1 diabetes